Rapport Therapeutics Inc

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$24.44

+0.72 (+3.04%)

As of Nov 7, 10:02 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 18 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target +84.9% upside

Low Target $32.24

Average Target $45.18

High Target $61.72

Current Price $24.44

Current
$24.44

Target
$45.18

$32.24 $45.18 avg $61.72

Scenario Analysis

Bear Case

$32.24

31.9%

Low target

Base Case

$45.18

+84.9%

Avg target

Bull Case

$61.72

+152.5%

High target

Risk/Reward

4.8x

Highly favorable

Price in Context

52-Week High

$52.93

-53.8% from high

52-Week Low

$22.06

+10.8% from low

Target vs 52W High

$45.18

-14.6% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	37	86%	$1,330.33	-1.7%
RDY Dr. Reddy's Laboratories	Sell	42	45%	—	+0.0%
JNJ Johnson & Johnson	Buy	30	70%	$299.55	+8.4%
MRK Merck & Co. Inc.	Buy	35	71%	$159.27	+8.5%
PFE Pfizer Inc.	Hold	34	38%	$33.90	+15.3%
BMY Bristol-Myers Squibb Co	Hold	34	41%	$174.50	+180.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	14	93%	$36.26	-46.1%
ZTS Zoetis Inc	Hold	22	41%	$209.87	+164.3%